Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007307Source: DataRank Database

Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer is a research paper published in Journal for ImmunoTherapy of Cancer (2023). On theSindex it has a DataRank of 1.2. It has been cited 49 times, with 41 citing works in its 1-hop citation network.

N/A

1.2DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access49 citations · 41 citing works in its network

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT04430712

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 5.64)OA: goldTopics (55)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 48%Citation Network 52%

Base Score Contribution

0.587

From this paper's citation signal

Citation Network Contribution

0.645

From 34 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 41 citers.

Beyond the Hazard Ratio
JACC CardioOncology20261 citations10 referencesContributes 0.069
Longitudinal Assessment of Subclinical Arterial Inflammation in Patients Receiving Immune Checkpoint Inhibitors by Sequential [ 18 F]FDG PET Scans
Circulation Cardiovascular Imaging20258 citations39 referencesContributes 0.056
Cardiac Adverse Events in Patients Receiving Immune Checkpoint Inhibitors in the Adjuvant Setting: An FDA Pooled Analysis
Annals of Noninvasive Electrocardiology20253 citations26 referencesContributes 0.053
Immune checkpoint inhibitors in cancer: the increased risk of atherosclerotic cardiovascular disease events and progression of coronary artery calcium
BMC Medicine202422 citations63 referencesContributes 0.050
Arterial inflammation on [18F]FDG PET/CT in melanoma patients treated with and without immune checkpoint inhibitors: CHECK-FLAME I
Atherosclerosis20248 citations52 referencesContributes 0.042

Authors (13)

Carlos A. Gongora ORCID,Jana Taron ORCID,Giselle Alexandra Suero‐Abreu ORCID,Júlia Karády ORCID,Hannah Gilman

Live enrichment

PubMed:37433718 PMC:PMC10347471 OpenAlex:https://openalex.org/W4383874885

Innovációs és Technológiai Minisztérium

Grant: 2020-4.1.1.-TKP2020

Innovációs és Technológiai Minisztérium

Grant: NVKP_16-1–2016-0017

Innovációs és Technológiai Minisztérium

Grant: ÚNKP-22-4-II-SE

Deutsche Forschungsgemeinschaft

Grant: TA 1438/1-2. T

AstraZeneca

Grant: NCT04430712

National Heart, Lung, and Blood Institute

Grant: R01HL130539, R01HL137562, R01HL159187, K24HL150238

NHLBI NIH HHS

Grant: R01 HL130539

NHLBI NIH HHS

Grant: K24 HL150238

NHLBI NIH HHS

Grant: R01 HL137562

NHLBI NIH HHS

Grant: R01 HL159187

National Institutes of Health

Grant: 5K24HL150238-05

Cardiovascular Diseases among Patients with Cancer and Patients living with HIV

National Institutes of Health

Grant: 1R01HL137562-01A1

Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R01HL130539-04

STOP-CA: Statins to prevent Cardiotoxicity from Anthracyclines

A. Curt Greer and Pamela Kohlberg, the Michael and Kathryn Park Endowed Chair in Cardiology

Hassenfeld Scholar Award

FWCI

5.64

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc

journalhttps://jitc.bmj.com/content/jitc/11/7/e007307.full.pdf

publisherhttps://jitc.bmj.com/content/jitc/11/7/e007307.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1136/jitc-2023-007307

journalhttps://doi.org/10.1136/jitc-2023-007307

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37433718

Fields of Study

Inflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersChemotherapy-induced cardiotoxicity and mitigation03 medical and health sciences0302 clinical medicineAgedFemaleHumansMaleMiddle AgedAtherosclerosisCombined Modality TherapyImmune Checkpoint InhibitorsLung NeoplasmsThoraxCase-Control Studies

MeSH Terms

Immune Checkpoint InhibitorsAgedCombined Modality TherapyFemaleHumansLung NeoplasmsMaleMiddle AgedThoraxCase-Control StudiesAtherosclerosis

Keywords

MedicineLung cancerCancerImmune systemImmune checkpointOncologyBioinformaticsCancer researchImmunologyImmunotherapyInternal medicineBiologyNon-small cell lung cancerImmune Checkpoint InhibitorsClinical/Translational Cancer ImmunotherapyMaleLung Neoplasms610Neoplasms. Tumors. Oncology. Including cancer and carcinogensMiddle AgedThoraxAtherosclerosisCombined Modality TherapyCase-Control StudiesHumansFemaleRC254-282Aged

Sustainable Development Goals

SDG 0: Good health and well-being